Experienced in Primary Lymphoma of the Brain

Myriam Chalabi

Amsterdam, NH, NL 
Experienced in Primary Lymphoma of the Brain
Amsterdam, NH, NL 
OverviewLocationsClinical Research

Overview

Myriam Chalabi practices in Amsterdam, Netherlands. Ms. Chalabi is rated as an Experienced expert by MediFind in the treatment of Primary Lymphoma of the Brain. Her top areas of expertise are Colorectal Cancer, Turcot Syndrome, Primary Lymphoma of the Brain, and Breast Cancer.

Her clinical research consists of co-authoring 35 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 1 article in the study of Primary Lymphoma of the Brain.

Gender
Female

Locations

Amsterdam, NH, Netherlands
Other Locations
Leiden, ZH, Netherlands

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

Perioperative Systemic Therapy and Cytoreductive Surgery with HIPEC Versus Upfront Cytoreductive Surgery with HIPEC Alone for Isolated Resectable Colorectal Peritoneal Metastases: a Multicentre, Open-label, Parallel-group, Phase II-III, Randomised Superiority Study
Perioperative Systemic Therapy and Cytoreductive Surgery with HIPEC Versus Upfront Cytoreductive Surgery with HIPEC Alone for Isolated Resectable Colorectal Peritoneal Metastases: a Multicentre, Open-label, Parallel-group, Phase II-III, Randomised Superiority Study
Enrollment Status: Active_not_recruiting
Publish Date: November 25, 2024
Intervention Type: Combination product, Procedure, Other
Study Phase: Phase 2/Phase 3

35 Total Publications

Nivolumab plus ipilimumab versus nivolumab in microsatellite instability-high metastatic colorectal cancer (CheckMate 8HW): a randomised, open-label, phase 3 trial.
Nivolumab plus ipilimumab versus nivolumab in microsatellite instability-high metastatic colorectal cancer (CheckMate 8HW): a randomised, open-label, phase 3 trial.
Journal: Lancet (London, England)
Published: December 09, 2024

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Chalabi's expertise for a condition
ConditionClose
      View All 8 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile